Pimavanserin is an approved selective 5-HT2A receptor inverse agonist for treating Parkinson’s disease psychosis. However, few studies on its metabolism in vitro have been investigated. In this research, eight strains of fungi are used to study the pimavanserin profiles and six them demonstrated positive transformation results. Factors influencing rate, like substrate concentration, culture tim...